ACRS Acquires Clinical Trial Site Network Elixia

American Clinical Research Services (ACRS) has acquired Elixia, a leading multispecialty clinical trial site network. Founded in 2019, Elixia focuses on trials in nephrology, neuroscience, and infectious diseases.

ACRS is an industry-leading clinical research entity, linking a vast network of multisite clinical research facilities with a global patient recruitment operation. It operates 12 sites nationwide, focusing on complex therapeutic areas and diverse patient populations. ACRS provides sponsors and contract research organizations with comprehensive patient recruitment and trial execution services.

Dustin Owen, chief executive officer of ACRS, said, “The integration of Elixia not only broadens our capabilities in nephrology but also enhances our collective expertise in neuroscience and allows us to multiply our sites capable of conducting complex metabolic indications.”

Elixia’s co-founder, Neal Patel, stated, “This union augments our resources, expands our site capabilities, and enhances our ability to launch and sustain studies that promise to dramatically improve patient outcomes.”